Colorectal Cancer Screening In Gastroenterology Units
Routine screening colonoscopy remains central to early colorectal cancer detection. The PCF-H180AI supports high adenoma detection rates through sharp high-definition imaging and Narrow Band Imaging compatibility, which helps endoscopists identify flat and subtle lesions during screening. Gastroenterology departments in tertiary hospitals and dedicated screening centres benefit most from its consistent image quality across high procedure volumes.
Therapeutic Polypectomy And Mucosal Resection
The wide working channel and responsive tip control make this colonoscope well suited for therapeutic interventions. Endoscopists can perform standard polypectomy, endoscopic mucosal resection, and haemostasis through compatible accessories during the same session. Ambulatory endoscopy suites and day-care therapeutic units find this dual capability valuable for reducing patient recalls and improving workflow efficiency.
Surveillance Colonoscopy In Diagnostic Centres
Patients with a history of adenomas, inflammatory bowel disease, or familial colorectal risk require ongoing surveillance. The PCF-H180AI delivers reproducible imaging quality suited to surveillance programmes where consistent documentation across repeat examinations is important. Diagnostic centres can integrate captured images into PACS and EMR systems to support long-term clinical follow-up.
Evaluation Of Lower Gastrointestinal Bleeding
In cases of suspected lower gastrointestinal bleeding, rapid and thorough mucosal inspection is essential. The scope's illumination, wide-angle view, and therapeutic channel support identification and management of bleeding sources during the same procedure. Emergency gastroenterology services and specialist referral hospitals benefit from this combined diagnostic and therapeutic capability.
Inflammatory Bowel Disease Assessment
For patients with ulcerative colitis or Crohn disease, detailed mucosal assessment guides treatment decisions. High-definition visualisation supports accurate scoring of disease activity and targeted biopsy sampling, making the PCF-H180AI a practical choice for specialist IBD clinics and research-oriented gastroenterology services.
